EN DE
STOCK COMPARISON

National Health Investors vs Welltower: Fair Value & Quality

Both stocks run through our valuation models. Here is how National Health Investors (NHI) and Welltower (WELL) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees National Health Investors as the less overvalued of the two: National Health Investors trades at $75.30 versus a fair value of $49.86 (-34%), while Welltower trades at $237 versus $35.88 (-85%).
National Health Investors
NHI · USD · Real Estate
-34%
upside to fair value
overvalued
Price$75.30
Fair Value$49.86
Quality56/100
Welltower
WELL · USD · Real Estate
-85%
upside to fair value
overvalued
Price$237
Fair Value$35.88
Quality42/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

National Health InvestorsWelltower
Valuation
22.8×P/E (TTM)112.4×
8.48×P/S (TTM)13.89×
2.26×P/B3.88×
15.3×EV/EBITDA59.4×
4.76×PEG3.62×
5.2%Dividend yield1.3%
$3.66Dividend per share$2.96
Profitability
37%Net margin12%
61%Operating margin18%
10%Return on equity4%
4%Return on assets1%
Growth
-3%Revenue growth (YoY)38%
10.8%Avg. growth/yr (3Y)22.7%
2.6%Avg. growth/yr (5Y)18.4%
Balance & size
0.63×Debt / equity0.46×
$3BMarket cap$163B
healthyGrowth qualityhealthy

National Health Investors leads: 9 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

National Health Investorsof which business quality 54 · market factors 56 Welltowerof which business quality 45 · market factors 79
ProfitabilityMargins and returns on capital today
39
21
Quality GrowthAre margins and returns improving?
34
51
CashflowEarnings quality: real cash, not paper profit
94
98
Fin. StrengthBalance sheet, leverage, solvency risk
42
50
InvestmentDisciplined investing over empire-building
78
33
Low VolatilityCalm price path (market factor)
89
82
MomentumPrice trend over the last 3–12 months (market factor)
42
72
52W MomentumDistance to the 52-week high (market factor)
42
89
Net IssuanceBuybacks instead of dilution
40
0

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

National Health Investors

DCF Models$59.47
Dividend Discount$56.71
Multiples$49.86
Asset-Based$21.03
Growth DCF$49.67
Economic Profit$29.44

14 of 16 models see the stock below the current price.

Welltower

DCF Models$70.62
Dividend Discount$46.81
Multiples$22.56
Asset-Based$39.99
Growth DCF$55.69
Economic Profit$41.32

14 of 14 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

National Health Investors
Bear $36.90Fair Value $49.86Bull $62.33
$75.30 = current price (white tick)
Welltower
Bear $26.72Fair Value $35.88Bull $35.88
$237 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

National Health Investors · Real Estate

Quality score56 · above median
Fair value upside-34% · below median

Welltower · Real Estate

Quality score42 · bottom 25%
Fair value upside-85% · bottom 25%

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees National Health Investors as the less overvalued of the two: National Health Investors trades at $75.30 versus a fair value of $49.86 (-34%), while Welltower trades at $237 versus $35.88 (-85%).

National Health Investors has the higher quality score (56/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.